BioSpace News Archive

Achieve Life Sciences, Inc. provided an update on the cytisinicline clinical development program and announced fourth quarter and year-end 2018 financial results.

Invitae Corporation announced that Sean George, co-founder and chief executive officer of Invitae, will present at the Oppenheimer 29th Annual Healthcare Conference on Wednesday, March 20, 2019 at 1:35 p.m. Eastern / 10:35 a.m. Pacific in New York City.

EnClear Therapies announced that the company had secured approximately $2 million in seed funding and that it has hired Kevin Kalish as Vice President of Research and Development.

Endo International plc (NASDAQ: ENDP) (“Endo”) today announced that Par Pharmaceutical, Inc. (the “Issuer”), its wholly-owned subsidiary, intends to offer senior secured notes, subject to market and customary conditions

Starlight Children’s Foundation, an organization dedicated to creating moments of joy and comfort for hospitalized kids and their families, announced today the return of its award-winning design competition, the ‘My Starlight Gown’ contest.

World Kidney Day – nearly halfway into March, National Kidney Month – and the National Kidney Foundation, Pro Football Hall of Famer Jerry Rice, and others committed to promoting kidney health are reminding everyone to “Heart Your Kidneys and score a touchdown for your kidney health.”

TSO3 Inc. (“TSO3" or the “Company”) (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced that the Company has initiated sterilization testing intended to support repeated sterile reprocessing in the TSO3 STERIZONE® VP4 Sterilizer of the Fujifilm ED-530XT duodenoscope supplied by FUJIFILM Medical Systems U.S.A., Inc.

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company, announced today that it has been selected to present LPCN 1144 clinical results as part of ENDO 2019.

MTF Biologics® announced today that its AmnioBand® Membrane line of aseptically processed human placental membrane allografts for use as acute or chronic wound coverings have received coverage from Anthem Insurance Companies, Inc.

Edasalonexent Phase 3 PolarisDMD Trial Globally Enrolling Boys with Duchenne Muscular Dystrophy